https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882449/
https://pubmed.ncbi.nlm.nih.gov/33603422/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1bQr69UjXVaRRUWkFKIzHYhAULOEOHnEnNj24W3oISCxcPMYuA&fc=None&ff=20210223145140&v=2.14.2
TITLE:
Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus
DESCRIPTION:
Type 1 diabetes mellitus (T1DM) results from the immune cell-mediated destruction of functional pancreatic β-cells. In the presymptomatic period, T1DM is characterized by the presence of two or more autoantibodies against the islet cells in patients without glycemic decompensation. Therapeutic strategies that can modify the autoimmune process could slow the progression of T1DM. Dipeptidyl peptidase-4 (DPP-4) or CD26, a multifunctional serine protease with a dual function (regulatory protease and…
PMID:
pubmed:33603422
DATE FOUND:
02/23/21 05:54PM
LINK / URL:
https://pubmed.ncbi.nlm.nih.gov/33603422/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1bQr69UjXVaRRUWkFKIzHYhAULOEOHnEnNj24W3oISCxcPMYuA&fc=None&ff=20210223145140&v=2.14.2
